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Most kidney stones are composed principally of calcium
oxalate. The major precursor of oxalate in man in glyoxylic
acid. Glycolic acid plays an intermediate role in glyoxylate
metabolism being involved in both its synthesis and degradation
[1]. The identification and differentiation of specific types of
kidney stone disease is partially based on the measurement of
glycolic acid [21. However, a large variation (Ito 100 mg124 hr)
in urinary glycolate values has been reported in the literature [3,
4]. Due to this variability the role of glycolic acid in the
diagnosis of nephrolithiasis is still mostly undetermined.
Several different methodologies exist for the measurement of
glycolate. These include chemical-colorimetric [5, 6], isotopic
dilution [7—9], chromatographic [3, 10—13], and enzymatic [4,
14—16]. All of these procedures have inherent problems associ-
ated with the determination of glycolic acid. These include
nonspecificity for the chemical-colorimetric methods, and tech-
nically complex isolation and derivitization steps for the gas-
liquid chromatographic and HPLC methods. Although the
enzymatic method appears to be the most widely used it suffers
from a number of drawbacks. These include the co-isolation of
glycolate and lactate from interfering substances found in urine,
by using a charcoal adsorption step. This necessitates the need
for a second separate assay for lactate with subsequent subtrac-
tion to correct for the glycolate values. Attempts at automation
have not been successful. The enzyme preparation is not stable
under these conditions and leads to a continuous reduction in
sensitivity, which could not be prevented by a number of
different approaches [4]. The method remains manual and
therefore time consuming.
We have used the technique of Automated Ion-Chromatog-
raphy to quantitate glycolic acid in urine. It has proven to be
reliable, reproducible, sensitive, specific, precise, and simple.
Methods
Reagents
Glycolic acid, oxalic acid and glycolate oxidase were pur-
chased from Sigma Chemical Company (St. Louis, Missouri,
USA). [l-'4C] Glycolic acid was from Amersham Corp. (Arling-
ton Heights, Illinois, USA).
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Sample collection
Twenty-four hour urines were collected in 20 ml concentrated
hydrochloric acid, which caused the pH of all the samples to be
less than 2. The urine pH and volume were recorded and the
entire collection was heated for 15 minutes at 50°C. Separate
aliquots were removed and stored frozen for the determination
of creatinine, oxalate, and glycolate.
Sample preparation
For the assay of both oxalate and glycolate, a 5 ml aliquot of
urine was processed by passage through a PrepSep C-l8 dis-
posable extraction column (Fisher Scientific), followed by 5 ml
of deionized water. C- 18 columns were prepared by flushing
with 5 ml methanol, followed by 15 ml deionized water. This
initial preparatory step satisfactorily cleared the urine of any
contaminating particulate material. An aliquot of the PrepSep
effluent was diluted 15-fold in water for the glycolate assay and
50-fold in 0.5 M boric acid for the assay of oxalate. Possible loss
of both glycolate and oxalate during this procedure was moni-
tored using [I-'4C] glycolic acid, and [l-'4C] oxalic acid. Total
recovery of both acids in this step was 99.8%.
Ion-exchange chromatography
Separation and quantitation of glycolate from other urinary
constituents was performed using a Dionex 4000i Series Gradi-
ent Ion Chromatography System (Dionex Corporation, Sunny-
vale, California, USA). This automated system consists of an
auto sampler, column module, gradient pump, conductivity
detector and programmable controller integrator. The sample is
filtered and then injected onto a CarboPac PAl anion exchange
analytical column. The eluant flow rate was 1.5 mI/mm. Back-
ground conductivity was minimized by using an anion micro-
membrane suppressor (AMMS) with a 25 m sulfuric acid
regenerant set at a flow rate of 9 mI/mm. The column eluant was
monitored using a conductivity cell set at 10.0 uSiemens full
scale, and peak areas recorded on a reporting integrator.
Glycolic acid standards in the range of 5 ng/pi to 100 ng/pJ
were prepared in distilled water. Standard curves based on peak
areas were made and glycolate was quantitated based on linear
regression analysis.
The Eluant Program consisted of: 19 mm at 12 m sodium
tetraborate; 5 mm at 50 m sodium carbonate; 10 mm at 50 mri
sodium tetraborate; and 26 mm at 12 m sodium tetraborate.
The initial removal of glycolate from the column is performed
using the low elution strength (12 mM) tetraborate buffer.
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Remaining anions and other urinary constituents are then
removed with the higher elution strength (50 mM) carbonate
buffer and (50 mM) tetraborate buffer. After this cleaning
process, 12 m tetraborate buffer is again used to gently
re-equilibrate to baseline.
Assay method for oxalic acid
Oxalic acid was also measured by ion-chromatography [17,
18], using the Dionex 4000i System. Two hundred microliters of
the processed sample (see sample preparation) was automati-
cally injected onto an AS4A anion exchange analytical column
containing an AG4 guard column. The eluant was a carbonate!
bicarbonate buffer, (2.80 mmol/liter Na2CO3 and 2.20 mmoll
liter NaHCO3, pH 9.50) used at a flow rate of 1.5 mI/mm. The
column eluant was monitored using a conductivity cell set at 3
uSiemens full scale, and peak areas were recorded. The same
suppressor system and conditions were used as for glycolate.
Sodium oxalate standards were prepared in 0.5 M boric acid.
The oxalate anion elutes at approximately 13 minutes. We have
incorporated the use of 0.5 M boric acid for dilution of urine
samples to prevent the possible conversion of urinary ascorbic
acid into oxalate during the analysis, as per the recommenda-
tion of Robertson and Scurr [191.
Assay method for creatinine
Creatinine was measured using a Gilford clinical chemistry
analyzer system 103. The test utilizes a modified kinetic proce-
dure as described by Fabiny and Ertingshausen [20].
Subjects
Normal subjects were active healthy individuals with no
history of either renal disease or renal stone disease. All were
on a normal diet without restrictions. Patients were individuals
with a history of calcium oxalate renal stone disease who were
classified by their clinical picture, blood chemistries and 24-
hour urinary excretions of calcium, uric acid and oxalate. No
attempt was made to change or control diet during the period of
the urine collections in any of the subjects.
Patients with a diagnosis of idiopathic nephrolithiasis had
normal renal function, normal blood chemistries and normal
excretion of calcium, oxalate and uric acid. Patients with a
diagnosis of primary hyperoxaluria type 1 had recurrent cal-
cium oxalate stones, persistently elevated levels of urinary
oxalate, a family history of hyperoxaluria, and a high glycolate/
creatinine ratio. One half of the patients (3 of 6) with primary
hyperoxaluria type 1 were taking pyridoxine supplementation
during the analysis. One patient was on no medication. No
information was available for the remaining two patients. The
patient with presumed type 2 primary hyperoxaluria had hyper-
oxaluria, with persistently normal urinary glycolate and glyco-
late/creatinine ratio. Patients with enteric hyperoxaluria had a
history of chronic bowel disease or jejunoileal bypass, steator-
rhea, recurrent calcium oxalate stones and hyperoxaluria. A
group of 14 patients with idiopathic calcium oxalate stones
exhibited modest hyperoxaluria, defined as urinary oxalate
excretion greater than 1 standard deviation above the mean.
Statistical analysis
Data were statistically evaluated by using correlation and
linear regression analyses, analysis of variance followed by
Scheffe's multiple comparison test, and were performed utiliz-
ing the program StatView (BrainPower Inc., Calabasas, Cali-
fornia, USA) on a Macintosh IIcx computer. P values smaller
than 0.05 (95% confidence) were used to indicate significant
differences.
Results
Figure 1A shows the ion-chromatographic conductivity elu-
tion profile of a 28.5 ng/p.l glycolic acid standard. Figure lB
shows the elution profile for a urine sample containing 27.1
ng/.d of glycolic acid. The retention time for standards and
urine samples was 19.9 minutes. A linear regression analysis
calibration curve for glycolic acid concentration as a function of
peak area gave an r2 value of 0.999.
Precision
Three different urine samples containing low (11 ng/.d) me-
dium (36 nglpi) and high (66 ngId) levels of glycolic acid were
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Fig. 1. A. The ion-chromatographic conductivity elution profile of a
28.5 ng/pJ glycolate standard. B. The ion-chromatographic conductiv-
ity elution profile for a urine sample containing 27.1 ng/pJ of glycolate.
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each assayed 12 times in a single run yielding an intra-assay
coefficient of variation of 1.2, 2.5 and 3.1%, respectively. These
samples were also assayed 12 different times in quadruplicate
giving an inter-assay coefficient of variation corresponding to
2.7, 1.4, and 2.3%.
Recovery studies
Three levels of glycolic acid (11, 28, and 57 nglpi) were each
added to the three different urine samples used in the precision
study. The overall mean recovery for all samples was 100.9%,
(range 92.6 to 108.4, N = 18), 104.5% for the low glycolate urine
group, 100.8% for the medium group, and 97.5% for the high
group.
Interference
Glyoxylic, acetic, succinic, oxalic, citric, ascorbic, glutamic,
glyceric, maleic, malonic, fumaric, malic, lactic, and pyruvic
acids at a concentration 10-fold higher than glycolic acid
produced no interference with the measurement of glycolic
acid.
Specificity
An aliquot of urine (glycolate conc. 64.0 ng/d) was prepared
using a modified method of Rose [21]. The urine pH was
adjusted to 7.5 with NaOH. The sample was incubated for two
hours at 37°C with 0.5 units of glycolate oxidase. The sample
was then centrifuged through a 10,000 molecular weight Cen-
tricon filter to remove protein, diluted with distilled water and
assayed. There was no detectable glycolate peak after treat-
ment with the enzyme.
One microcurie of [1-14C1 labeled glycolic acid was added to
both a glycolic acid standard and a urine sample. The radioac-
tivity profile superimposed on the conductivity elution profile
for glycolic acid in both samples, indicating the identity of the
peak. A minor radioactive peak (2.8% of total cpm) also eluted
five minutes prior to the major glycolic acid peak. This was
thought to be due to an impurity in the radioactive label since
the manufacturer listed a 98% purity for the product.
Sensitivity
The lowest glycolate level which can be detected with this
method is 0.191 ng/pi. Since the lowest measured urinary
glycolate value in the study was 1.8 nglp.l (approximately
10-fold higher), the method appears to be sensitive enough to
assay low urinary glycolate levels.
Storage
Glycolate standards and urine samples frozen at —20°C for
nine months produced no significant change in the level of
measured glycolic acid.
Glycolate levels
Table 1 shows the urinary glycolic acid and oxalic acid levels
for different groups of subjects. Values are given as mg124 hr,
and mg per mg creatinine. The mean 1 SD urinary glycolate
level for group 1 (normal adults) was 36.6 15.8 mg/24 hr, with
a range of 11 to 81. Values for females tended to be higher than
males (ANOVA:Scheffe's; 95% confidence). There was no
statistical significant correlation between glycolate and oxalate
levels (r2 = 0.31; P = 0.0002).
Group 2 consisted of 50 patients with idiopathic stone dis-
ease. The mean 1 SD urinary glycolate for this group was 24.4
18.1 mg/24 hr, with a range of 5 to 83. There was no
significant difference between males and females. There was
again no statistically significant correlation between glycolate
and oxalate levels (r2 = 0.15; P = 0.006). There was also no
significant difference between the mean in this group and the
mean in the controls.
Group 3 contained 14 patients exhibiting modest hyperox-
aluria. The mean level of glycolate in this group was 34.0 29.4
mg/24 hr, with a range of 3 to 87. There was no significant
difference between the mean glycolate in this group and the
mean in the controls.
Group 4 consisted of five patients with enteric hyperoxaluria.
Although the 24-hour oxalic acid level was significantly ele-
vated in this group, the mean 24-hour urinary glycolate level
was not significantly different from controls.
Group 5 included six patients with primary hyperoxaluria
type 1. We were able to obtain complete 24 hour collections on
only four of these six patients. The mean level of glycolate in
this group was 76.9 38.7 mg/24 hr with a range of 40 to 112 (N
= 4). What was especially interesting in this group was the
approximately ninefold increase in the glycolate to creatinine
ratio (N = 6).
Group 6 contained one patient with presumed primary hyper-
oxaluria type 2. Although the level of oxalic acid in this patient
was significantly increased, neither the 24-hour glycolate level
nor the glycolate/creatinine ratio was different from controls. In
fact, the glycolic acid level in this patient fell below the lower
limit seen in control subjects.
Figure 2 shows the urinary glycolic acid and glycolate/
creatinine ratios from one normal control patient over a contin-
uous 32-day period. This figure displays the daily variability of
glycolate levels within this one subject. This degree of variabil-
ity was also seen in four other normal subjects when studied
over five consecutive days. The coefficient of variation for the
daily creatinine values was lower than that for glycolate,
implying that the glycolate/creatinine ratio variability was
mostly dependent on the glycolate values.
Discussion
With the introduction of automated systems such as the
Dionex 4000i, the ability to analyze urinary constituents in-
volved in stone disease has become routine. We have now
demonstrated the competence of this system to effectively
quantitate glycolic acid levels in urine. A definite advantage of
this technique is that it is automated, thereby significantly
decreasing technician time required for analysis. A quick pre-
liminary preparatory step followed by dilution is all that is
required for analysis. The system can function continuously 24
hours a day.
Table 2 shows the normal values for glycolic acid obtained
using different techniques. The levels of glycolic acid vary
considerably independent of the methods. The reported range
for glycolate is ito 100 mg/24 hr. We also detected a wide range
from 11 to 81 mg/24 hr for normal controls in this study.
Due to the considerable variability in daily glycolate levels,
caution must be used in evaluating a single 24-hour glycolate
measurement. A much better indicator for determining the
different hyperoxaluric types is the glycolate/creatinine ratio. In
768 Wandzilak et a!: Glycolate in urine by ion-chromatography
Values are: a mean SD; b range; C median; (I mg glycolate/mg creatinine
our study, for all the cases of primary hyperoxaluria type 1, the
ratio of glycolate/creatinine was significantly elevated com-
pared to controls, even though 24-hour urinary glycolate levels
may not have been significantly increased. Daily 24-hour ox-
alate values exhibited a narrower range than concomitant
24-hour glycolate values, confirmed by a lesser coefficient of
variation.
in this study 22% of patients with idiopathic calcium oxalate
stone disease exhibited a modest (group 3), yet physiologically
significant increase in urinary oxalate. This condition has been
referred to by Robertson and Peacock [22] as "mild hyperox-
aluria". A review of the literature has shown that a number of
studies [22—28] have reported this finding, and that a decisive
number (20 to 50%) of patients with idiopathic calcium oxalate
stone disease exhibit a mild elevation of urinary oxalate. This
mild augmentation in oxalate excretion, even for brief periods
of time, could potentially provoke urinary precipitation of
calcium oxalate. Even though there was a significant elevation
in urinary oxalate in this group, the overall mean 24-hour
urinary glycolate levels and the glycolate/creatinine ratios were
not statistically significantly different from controls, nor from
the idiopathic group (group 2), which did not show a mild
elevation of urinary oxalate.
In five of the 14 subjects with modest hyperoxaluria (group
Table 1. Urinary glycolate and oxalate values for different groups of subjects
Glycolate Oxalate
mg/24 hrmg/24 hr /creatinine" /creatinine
Group I Control
N = 41
36.6 l5.8
1181b
0.025 0,012
0.009—0.054
28.6 9.9
1l-56
0.020 0.007
0.009—0.044
33.8C 0.023 28.6 0.020
Female 42.9 16.1 0.034 0.012 28.2 9.8 0.023 0.007
N = 17 1l—67 0.018—0.054 11—50 0.013—0.044
37.9 0.031 30.2 0.023
Male 32.1 14.3 0.019 0.006 28.9 10.3 0.018 0.007
N = 24 14—81 0.009—0.035 11—56 0.009—0.036
31 0.019 28.2 0.018
Group 2 IdiopathicN = 50
Female
N = 22
Male
N = 28
24.4 18.1
5—83
19.2
20.1 18.8
5—83
13.7
27.8 17.0
8—71
24.3
0.023 0.013
0.008—0.078
0.021
0.024 0.012
0.009—0.060
0.021
0.023 0.013
0.008—0.078
0.021
27.5 8.3
13—43
27.1
22.9 6.8
14—38
21.3
31.0 7.7
13-43
31.8
0.030 0.011
0,010-0.069
0.029
0.032 0.012
0.010—0.069
0.031
0.027 0.010
0.016-0.067
0.026
Group 3 Modest
hyperoxalunaN = 14
Female
N = 6
Male
N = 8
34.0 29.4
3—87
23.1
38.3 35.5
3—87
34.9
30.8 25.9
6—80
23.1
0.024 0,019
0.005—0.066
0.019
0.026 0.020
0.005—0.050
0.021
0.023 0.019
0.008—0.066
0.019
57.3 9.1
44—75
58.0
52.9 6.3
46—63
53.4
60.5 9.8
44—75
62.4
0.055 0.029
0.026—0.120
0.050
0.059 0.039
0.026—0.120
0.042
0.053 0.022
0.026—0.095
0.052
Group 4 Enteric
hyperoxaluriaN = 5
Female
N = 4
Male
N=1
31.5 11
16—43
36.3
28.7 11
16—39
29.6
42.5
0.023 0.006
0.017—0.030
0.021
0.025 0.006
0.018—0.030
0.025
0.017
76.5 32.0
41—123
83.7
85.3 29.4
51—123
83.8
41.3
0.072 0.051
0.017—0.138
0.064
0.085 0.048
0.03—0.138
0.087
0.017
Group 5 Primary
hyperoxaluria 1
N=4—6
Female
N = 3
Male
N = 1—3
76.9 38.7
40—112
77.9
(N=4)
66.3 39.6
40—112
46.9
108.9
(N=l)
0.214 0.125
0,075—0.373
0.205(N=6)
0.246 0.093
0.145—0.328
0.264
0.183 0.165
0.075—0.373
0.101
(N—3)
91.4 39.8
56—147
81.1
(N=4)
91.5 48,7
56—147
71.2
190.9
(N=l)
0.304 0.155
0.084-0.496
0.314
(N=6)
0.353 0.153
0.191—0.496
0.371
0.256 0.172
0.084—0.427
0.257
(N=3)
Group 6 Primary
hyperoxaluria 2
N = I male
8.2 0.017 116.3 0.236
0.04
C)
00
0
CD
0.03 C)
CDa
CD
Table 2. Reported urinary glycolate levels
Name Date Method Type mg/24 hr Range # Subjects
Hockaday et al [71 1965 Isotopic dilution 35.1 18.2—60.7 19
Zarembski [5] 1968 Colorimetric 43.3 19.8—60.8 20
Thomas et a! [3] 1970 Gas chromatography 25.9 1—84 43
Earnest et a! [8] 1974 Isotopic dilution 42 6 9
Johansson & Tabova [91 1974 Isotopic dilution 11.1—45.0
Chalmers & Watts [14] 1978 Gas chromatography 25.1 9.9—45.6
Niederwieser et al [6] 1978 Colorimetric 45.8 11 22.2—69.0 15
Kasidas & Rose [14] 1979 Enzyme 14.4 7.6—34.2 61
Bais et al [4] 1985 Enzyme 9.9—99.6 50
Cowley et a! [15] 1987 Enzyme 36.6 15.5 9
Costello et a! [161 1989 Enzyme 47.1 27.4 13
Hughes et al [131 1989 Ion chromatography 42.5 13.7 24
Petrarulo et al [121 1989 HPLC 34.2 10.6 15.7—55.6 25
3), urinary glycolate values were greater than 1 SD above the
mean of the control group, yet these levels were within the
range of normal urinary glycolate. The mechanism for this
apparent increase in urinary glycolate in these five patients is
unknown, but it could result from an increased ingestion of
dietary glycolate, increased intestinal absorption, increased
renal clearance or increased endogenous production. We have
no data yet to identify which of these mechanisms is involved.
The levels of glycolate and oxalate in these five patients are
similar to those in a group of patients termed by Gill and Rose
[29] as "mild metabolic hyperoxaluria", also reported by Yendt
and Cohanim [301.
In another study by Yendt and Cohanim [311 urinary glyco-
late excretion was elevated in 21 of 74 patients (28%) with
calcium oxalate stones. Urinary glycolate correlated positively
with a number of urinary constituents including creatinine,
calcium, phosphate, body weight and uric acid. However, the
strongest correlation (r = 0.62, P < 0.001), and the only
predictor of urinary glycolate levels was urinary uric acid. They
hypothesized that the increased urinary glycolate might be a
reflection of increased dietary protein intake, based on the
demonstration that in a subset (N 5) of patients with high
urinary glycolate excretion who decreased their dietary intake
of animal protein by 50% for one week, there was a significant
fall in both urinary oxalate and glycolate. Therefore, it is
possible that the factor responsible for the elevated glycolate
60
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Fig. 2. Glycolate (mg/24 hr) and glycolate/creatinine ratio
for I control subject for a continuous 32 day period.
Symbols are: (Li]) glycolate; (U) glycolate/creatinine.
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values seen in our five subjects with modest hyperoxaluria is
related to dietary animal protein intake. Since no dietary
records are available on these subjects, this suggestion is
speculative.
Due to the daily variability of urinary glycolate values it is
important to be cautious in the interpretation of a single
glycolate determination. Therefore, we recommend that a se-
ries of measurements be made in order to validate the level.
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